ReviewImpact of iron overload in myelodysplastic syndromes
References (54)
- et al.
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience
Blood
(2008) - et al.
Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients
Blood
(1989) - et al.
Non-transferrin-bound iron in plasma or serum from patients with idiopathic haemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy
J Biol Chem
(1989) - et al.
Newly delivered transferrin iron and oxidative cell injury
FEBS Lett
(1997) - et al.
Iron in the heart. Etiology and clinical significance
Am J Med
(1971) - et al.
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool
Blood
(2003) - et al.
Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli
Blood
(2009) - et al.
Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I
Blood
(2008) - et al.
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
Blood
(2009) - et al.
Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness
Blood
(2009)
Natural history of idiopathic refractory sideroblastic anemia
Blood
(1988)
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation
Blood
(2007)
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)
Biol Blood Marrow Transplant
(2008)
Nontransferrin-bound iron in serum of patients receiving bone marrow transplants
Free Radic Biol Med
(1997)
Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia
Blood
(1969)
Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron
FEMS Immunol Med Microbiol
(2003)
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics
Int J Hematol
(2001)
Myelodysplastic syndromes: incidence and survival in the United States
Cancer
(2007)
Erythroid activity, transfusion iron overload, and hepcidin levels in patient with myelodysplastic syndrome
Blood
(2008)
Practical management of iron overload
Br J Haematol
(2001)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
J Clin Oncol
(2005)
A pilot MRI study of organ specific hemosiderosis and functional correlation in Chinese patients with myelodyplasia and aplastic anemia with raised ferritin levels
Hematol Oncol
(2008)
Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions
Br J Haematol
(2007)
Selective iron deposition in pancreatic islet B cells of transfusional iron-overloaded autopsy cases
Pathol Int
(1994)
No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2* technique
Am J Hematol
(2007)
Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias
Haematologica
(2008)
Cited by (0)
Copyright © 2009 Elsevier Ltd. All rights reserved.